Stock Taper

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF • Roundhill Investments

$35.74 ▲ 0.03% (+0.01)

Managing Company Roundhill Investments

Asset Under Management $48.48M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $36.49

52w Low $20.01

Volume 31,997

Avg Volume 18,417

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

Managing Company Roundhill Investments

Asset Under Management $48.48M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $36.49

52w Low $20.01

Volume 31,997

Avg Volume 18,417

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
NVO	Novo Nordisk A/S	21.15%	187.51K	$10.61M
LLY	Eli Lilly and Company	15.95%	7.22K	$8.00M
VKTX	Viking Therapeutics, Inc.	3.92%	60.69K	$1.97M
PFE	Pfizer Inc.	3.92%	77.75K	$1.97M
GPCR	Structure Therapeutics Inc.	3.75%	28.37K	$1.88M
AMGN	Amgen Inc.	3.61%	5.30K	$1.81M
AZN	AstraZeneca PLC	3.19%	16.84K	$1.60M
REGN	Regeneron Pharmaceuticals, Inc.	2.87%	1.77K	$1.44M
SRRK	Scholar Rock Holding Corporation	1.87%	21.24K	$939.40K
GILD	Gilead Sciences, Inc.	1.85%	7.46K	$928.02K
BHVN	Biohaven Ltd.	1.78%	76.00K	$892.30K
RYTM	Rhythm Pharmaceuticals, Inc.	1.34%	6.63K	$673.74K
WVE	Wave Life Sciences Ltd.	0.86%	27.98K	$431.71K

SECTOR HOLDINGS

Healthcare

Healthcare

98.76%

Cash & Others

Cash & Others

1.07%

Technology

Technology

0.13%

Financial Services

Financial Services

0.04%

ASSET ALLOCATION BY REGION

United States

40.10%

Denmark

28.19%

China

12.29%

Japan

5.32%

Switzerland

4.13%

South Korea

3.49%

United Kingdom

3.25%

Hong Kong

2.08%

Singapore

0.86%

Other

0.28%

SECTOR HOLDINGS

Healthcare

Healthcare

98.76%

Cash & Others

Cash & Others

1.07%

Technology

Technology

0.13%

Financial Services

Financial Services

0.04%

ASSET ALLOCATION BY REGION

United States

40.10%

Denmark

28.19%

China

12.29%

Japan

5.32%

Switzerland

4.13%

South Korea

3.49%

United Kingdom

3.25%

Hong Kong

2.08%

Singapore

0.86%

Other

0.28%

Holdings (Top 20)

NVO

NVO

Novo Nordisk A/S

Weight: 21.15% Shares: 187.51K Value: $10.61M

LLY

LLY

Eli Lilly and Company

Weight: 15.95% Shares: 7.22K Value: $8.00M

VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 3.92% Shares: 60.69K Value: $1.97M

PFE

PFE

Pfizer Inc.

Weight: 3.92% Shares: 77.75K Value: $1.97M

GPCR

GPCR

Structure Therapeutics Inc.

Weight: 3.75% Shares: 28.37K Value: $1.88M

AMGN

AMGN

Amgen Inc.

Weight: 3.61% Shares: 5.30K Value: $1.81M

AZN

AZN

AstraZeneca PLC

Weight: 3.19% Shares: 16.84K Value: $1.60M

REGN

REGN

Regeneron Pharmaceuticals, Inc.

Weight: 2.87% Shares: 1.77K Value: $1.44M

SRRK

SRRK

Scholar Rock Holding Corporation

Weight: 1.87% Shares: 21.24K Value: $939.40K

GILD

GILD

Gilead Sciences, Inc.

Weight: 1.85% Shares: 7.46K Value: $928.02K

BHVN

BHVN

Biohaven Ltd.

Weight: 1.78% Shares: 76.00K Value: $892.30K

RYTM

RYTM

Rhythm Pharmaceuticals, Inc.

Weight: 1.34% Shares: 6.63K Value: $673.74K

WVE

WVE

Wave Life Sciences Ltd.

Weight: 0.86% Shares: 27.98K Value: $431.71K